{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T01:29:24Z","timestamp":1758158964844,"version":"3.44.0"},"reference-count":297,"publisher":"Elsevier","isbn-type":[{"type":"print","value":"9780323856522"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/b978-0-323-85652-2.00019-1","type":"book-chapter","created":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T05:01:30Z","timestamp":1630040490000},"page":"107-145","source":"Crossref","is-referenced-by-count":1,"title":["Metabolic regulation in urological tumors: Interplay with epigenetics and epitranscriptomics"],"prefix":"10.1016","author":[{"given":"Vera","family":"Miranda-Gon\u00e7alves","sequence":"first","affiliation":[]},{"given":"Catarina","family":"Guimar\u00e3es-Teixeira","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Henrique","sequence":"additional","affiliation":[]},{"given":"Carmen","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.canlet.2020.01.021","article-title":"Writers, readers and erasers of RNA modifications in cancer","volume":"474","author":"Esteve-Puig","year":"2020","journal-title":"Cancer Lett"},{"issue":"4\u20136","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0015","first-page":"82","article-title":"An introduction to modern genetics","volume":"14","author":"Waddington","year":"1939","journal-title":"Proc. R. Entomol. Soc. London. Series A, Gen. Entomol."},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0020","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/s41392-019-0095-0","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct Target Ther"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0025","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1021\/ja01688a030","article-title":"Researches on pyrimidines. C111. The discovery of 5-methyl-cytosine in tuberculinic acid, the nucleic acid of the Tubercle bacillus","volume":"47","author":"Johnson","year":"1925","journal-title":"J Am Chem Soc"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/npp.2012.112","article-title":"DNA methylation and its basic function","volume":"38","author":"Moore","year":"2013","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0035","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1042\/EBC20190037","article-title":"The DNA methylation landscape in cancer","volume":"63","author":"Skvortsova","year":"2019","journal-title":"Essays Biochem"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1007362","article-title":"Cancer epigenetics: moving forward","volume":"14","author":"Nebbioso","year":"2018","journal-title":"PLoS Genet"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0045","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1261\/rna.063503.117","article-title":"The RNA modification landscape in human disease","volume":"23","author":"Jonkhout","year":"2017","journal-title":"RNA"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0050","first-page":"1","article-title":"RNA modifications and cancer","author":"Haruehanroengra","year":"2020","journal-title":"RNA Biol"},{"issue":"8","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0055","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3390\/cells8080798","article-title":"Metabolic Dysregulations and epigenetics: a bidirectional interplay that drives tumor progression","volume":"8","author":"Crispo","year":"2019","journal-title":"Cell"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0060","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nrc.2016.82","article-title":"Metabolic control of epigenetics in cancer","volume":"16","author":"Kinnaird","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3389\/fgene.2018.00427","article-title":"Metabolism and epigenetic interplay in cancer: regulation and putative therapeutic targets","volume":"9","author":"Miranda-Gon\u00e7alves","year":"2018","journal-title":"Front Genet"},{"issue":"8","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0070","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"6348","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0080","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"issue":"Suppl. 1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0085","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/ncponc0354","article-title":"DNA methylation and gene silencing in cancer","volume":"2","author":"Baylin","year":"2005","journal-title":"Nat Clin Pract Oncol"},{"issue":"21","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0090","doi-asserted-by":"crossref","first-page":"18347","DOI":"10.1074\/jbc.R110.205286","article-title":"DNA methylation and demethylation in mammals","volume":"286","author":"Chen","year":"2011","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0095","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1101\/gad.179184.111","article-title":"Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation","volume":"25","author":"Wu","year":"2011","journal-title":"Genes Dev"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv Genet"},{"issue":"8","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0105","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nrg1655","article-title":"DNA methylation and human disease","volume":"6","author":"Robertson","year":"2005","journal-title":"Nat Rev Genet"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0110","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0115","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0120","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-016-0279-9","article-title":"Targeting histone methylation for cancer therapy: enzymes, inhibitors, biological activity and perspectives","volume":"9","author":"Song","year":"2016","journal-title":"J Hematol Oncol"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0125","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2007.01.015","article-title":"The role of chromatin during transcription","volume":"128","author":"Li","year":"2007","journal-title":"Cell"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.biochem.70.1.81","article-title":"Histone acetyltransferases","volume":"70","author":"Roth","year":"2001","journal-title":"Annu Rev Biochem"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0135","doi-asserted-by":"crossref","first-page":"a018713","DOI":"10.1101\/cshperspect.a018713","article-title":"Erasers of histone acetylation: the histone deacetylase enzymes","volume":"6","author":"Seto","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0140","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1080\/14756366.2017.1417274","article-title":"Zinc binding groups for histone deacetylase inhibitors","volume":"33","author":"Zhang","year":"2018","journal-title":"J Enzyme Inhib Med Chem"},{"issue":"6771","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0145","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35001622","article-title":"Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase","volume":"403","author":"Imai","year":"2000","journal-title":"Nature"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0150","first-page":"5519","article-title":"Emerging function of N6-methyladenosine in cancer","volume":"16","author":"Hong","year":"2018","journal-title":"Oncol Lett"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0155","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1021\/acs.biochem.8b00949","article-title":"RNA modifications: reversal mechanisms and cancer","volume":"58","author":"Thapar","year":"2019","journal-title":"Biochemistry"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0160","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0165","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1158\/0008-5472.CAN-18-2965","article-title":"The critical role of RNA m(6)A methylation in cancer","volume":"79","author":"Lan","year":"2019","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0170","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrm.2016.132","article-title":"Post-transcriptional gene regulation by mRNA modifications","volume":"18","author":"Zhao","year":"2017","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7540","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0175","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/nature14234","article-title":"N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions","volume":"518","author":"Liu","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0180","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ncb2902","article-title":"N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells","volume":"16","author":"Wang","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"7481","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nature12730","article-title":"N6-methyladenosine-dependent regulation of messenger RNA stability","volume":"505","author":"Wang","year":"2014","journal-title":"Nature"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molcel.2016.03.021","article-title":"The m(6)A methyltransferase METTL3 promotes translation in human cancer cells","volume":"62","author":"Lin","year":"2016","journal-title":"Mol Cell"},{"issue":"7574","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0195","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature15377","article-title":"Dynamic m(6)A mRNA methylation directs translational control of heat shock response","volume":"526","author":"Zhou","year":"2015","journal-title":"Nature"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0200","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.cell.2015.05.014","article-title":"N(6)-methyladenosine modulates messenger RNA translation efficiency","volume":"161","author":"Wang","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0205","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2015.10.012","article-title":"5\u2032 UTR m(6)A promotes cap-independent translation","volume":"163","author":"Meyer","year":"2015","journal-title":"Cell"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.molcel.2016.01.012","article-title":"Nuclear m(6)A reader YTHDC1 regulates mRNA splicing","volume":"61","author":"Xiao","year":"2016","journal-title":"Mol Cell"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0215","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/cr.2014.151","article-title":"FTO-dependent demethylation of N6-methyladenosine regulates mRNA splicing and is required for adipogenesis","volume":"24","author":"Zhao","year":"2014","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0220","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.molcel.2012.10.015","article-title":"ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility","volume":"49","author":"Zheng","year":"2013","journal-title":"Mol Cell"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0225","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0230","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nsmb.3148","article-title":"N6-methyladenosine in mRNA disrupts tRNA selection and translation-elongation dynamics","volume":"23","author":"Choi","year":"2016","journal-title":"Nat Struct Mol Biol"},{"issue":"Database issue","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0235","first-page":"D262","article-title":"MODOMICS: a database of RNA modification pathways\u20142013 update","volume":"41","author":"Machnicka","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0240","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nmeth.4110","article-title":"Epitranscriptome sequencing technologies: decoding RNA modifications","volume":"14","author":"Li","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cbpa.2017.10.008","article-title":"Epitranscriptomics: regulation of mRNA metabolism through modifications","volume":"41","author":"Peer","year":"2017","journal-title":"Curr Opin Chem Biol"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0250","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/gb-2012-13-10-175","article-title":"The birth of the epitranscriptome: deciphering the function of RNA modifications","volume":"13","author":"Saletore","year":"2012","journal-title":"Genome Biol"},{"issue":"5503","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0255","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/255028a0","article-title":"Modified nucleosides and bizarre 5\u2032-termini in mouse myeloma mRNA","volume":"255","author":"Adams","year":"1975","journal-title":"Nature"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0260","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1073\/pnas.71.10.3971","article-title":"Identification of methylated nucleosides in messenger RNA from Novikoff hepatoma cells","volume":"71","author":"Desrosiers","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0265","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1093\/nar\/2.10.1653","article-title":"The methylation state of poly A-containing messenger RNA from cultured hamster cells","volume":"2","author":"Dubin","year":"1975","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0270","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0092-8674(75)90159-2","article-title":"The methylated constituents of L cell messenger RNA: evidence for an unusual cluster at the 5\u2032 terminus","volume":"4","author":"Perry","year":"1975","journal-title":"Cell"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0275","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.cell.2012.05.003","article-title":"Comprehensive analysis of mRNA methylation reveals enrichment in 3\u2032 UTRs and near stop codons","volume":"149","author":"Meyer","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0280","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41580-019-0168-5","article-title":"Reading, writing and erasing mRNA methylation","volume":"20","author":"Zaccara","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"13","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0285","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1101\/gad.262766.115","article-title":"RNA N6-methyladenosine methylation in post-transcriptional gene expression regulation","volume":"29","author":"Yue","year":"2015","journal-title":"Genes Dev"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0290","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/0300-9084(94)90038-8","article-title":"N6-adenosine methylation in mRNA: substrate specificity and enzyme complexity","volume":"76","author":"Rottman","year":"1994","journal-title":"Biochimie"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0295","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/cr.2014.3","article-title":"Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase","volume":"24","author":"Ping","year":"2014","journal-title":"Cell Res"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0300","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA mediates preferential m6A mRNA methylation in 3\u2032UTR and near stop codon and associates with alternative polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discovery"},{"issue":"5\u20136","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0305","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1101\/gad.309146.117","article-title":"Zc3h13\/Flacc is required for adenosine methylation by bridging the mRNA-binding factor Rbm15\/Spenito to the m(6)A machinery component Wtap\/Fl(2)d","volume":"32","author":"Knuckles","year":"2018","journal-title":"Genes Dev"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0310","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.molcel.2018.02.015","article-title":"Zc3h13 regulates nuclear RNA m(6)A methylation and mouse embryonic stem cell self-renewal","volume":"69","author":"Wen","year":"2018","journal-title":"Mol Cell"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0315","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.15252\/embr.201744940","article-title":"Human METTL16 is a N(6)-methyladenosine (m(6)A) methyltransferase that targets pre-mRNAs and various non-coding RNAs","volume":"18","author":"Warda","year":"2017","journal-title":"EMBO Rep"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0320","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev-cellbio-100616-060758","article-title":"Rethinking m(6)A readers, writers, and erasers","volume":"33","author":"Meyer","year":"2017","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0325","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nchembio.687","article-title":"N6-methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO","volume":"7","author":"Jia","year":"2011","journal-title":"Nat Chem Biol"},{"issue":"7637","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0330","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature21022","article-title":"Reversible methylation of m(6)A(m) in the 5\u2032 cap controls mRNA stability","volume":"541","author":"Mauer","year":"2017","journal-title":"Nature"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0335","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0340","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab"},{"issue":"3191","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0345","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"3215","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0350","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.124.3215.269","article-title":"On respiratory impairment in cancer cells","volume":"124","author":"Warburg","year":"1956","journal-title":"Science"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0355","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrc1478","article-title":"Why do cancers have high aerobic glycolysis?","volume":"4","author":"Gatenby","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0360","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.canlet.2020.02.034","article-title":"The metabolic landscape of urological cancers: new therapeutic perspectives","volume":"477","author":"Miranda-Goncalves","year":"2020","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0365","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2174\/18715206113136660337","article-title":"Glucose-6-phosphate dehydrogenase: a biomarker and potential therapeutic target for cancer","volume":"14","author":"Zhang","year":"2014","journal-title":"Anticancer Agents Med Chem"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0370","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metab"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0375","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.semcdb.2012.02.002","article-title":"Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis","volume":"23","author":"Daye","year":"2012","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0380","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4062\/biomolther.2017.178","article-title":"Targeting glutamine metabolism for cancer treatment","volume":"26","author":"Choi","year":"2018","journal-title":"Biomol Ther (Seoul)"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0385","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrclinonc.2016.60","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0390","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrc2222","article-title":"Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis","volume":"7","author":"Menendez","year":"2007","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0395","first-page":"27","article-title":"Lipid metabolism reprogramming and its potential targets in cancer","volume":"38","author":"Cheng","year":"2018","journal-title":"Cancer Commun (Lond)"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0400","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1101\/gad.1987211","article-title":"Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress","volume":"25","author":"Zaugg","year":"2011","journal-title":"Genes Dev"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0405","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/bjc.2017.118","article-title":"One-carbon metabolism in cancer","volume":"116","author":"Newman","year":"2017","journal-title":"Br J Cancer"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0410","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1083\/jcb.201803061","article-title":"Metabolic regulation of chromatin modifications and gene expression","volume":"217","author":"Schvartzman","year":"2018","journal-title":"J Cell Biol"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0415","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cmet.2017.02.003","article-title":"Metabolic inputs into the epigenome","volume":"25","author":"Sharma","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0420","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.semcancer.2019.06.006","article-title":"Connections between metabolism and epigenetics in cancers","volume":"57","author":"Thakur","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0425","first-page":"8(8)","article-title":"Metabolic dysregulations and epigenetics: a bidirectional interplay that drives tumor progression","author":"Crispo","year":"2019","journal-title":"Cells"},{"issue":"18","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0430","doi-asserted-by":"crossref","first-page":"8202","DOI":"10.18632\/oncotarget.1159","article-title":"Tissue-specific isoform switch and DNA hypomethylation of the pyruvate kinase PKM gene in human cancers","volume":"5","author":"Desai","year":"2014","journal-title":"Oncotarget"},{"issue":"27","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0435","doi-asserted-by":"crossref","first-page":"41798","DOI":"10.18632\/oncotarget.9723","article-title":"Regulation of HK2 expression through alterations in CpG methylation of the HK2 promoter during progression of hepatocellular carcinoma","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0440","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nbd.2011.06.007","article-title":"Developmental profile and regulation of the glycolytic enzyme hexokinase 2 in normal brain and glioblastoma multiforme","volume":"44","author":"Wolf","year":"2011","journal-title":"Neurobiol Dis"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0445","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0025564","article-title":"Promoter hypermethylation mediated downregulation of FBP1 in human hepatocellular carcinoma and colon cancer","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0450","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ccr.2013.01.022","article-title":"Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer","volume":"23","author":"Dong","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0455","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066294","article-title":"Suppression of gluconeogenic gene expression by LSD1-mediated histone demethylation","volume":"8","author":"Pan","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0460","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semcancer.2018.09.002","article-title":"Epigenetic modulation of metabolism in glioblastoma","volume":"57","author":"Dong","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0465","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1038\/ncomms4608","article-title":"A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect","volume":"5","author":"Lopez-Serra","year":"2014","journal-title":"Nat Commun"},{"issue":"27","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0470","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1038\/onc.2017.13","article-title":"Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1\u03b1","volume":"36","author":"Wan","year":"2017","journal-title":"Oncogene"},{"issue":"49","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0475","doi-asserted-by":"crossref","first-page":"E3367","DOI":"10.1073\/pnas.1217394109","article-title":"Histone demethylase JMJD2C is a coactivator for hypoxia-inducible factor 1 that is required for breast cancer progression","volume":"109","author":"Luo","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0480","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nrc3985","article-title":"The multifaceted functions of sirtuins in cancer","volume":"15","author":"Chalkiadaki","year":"2015","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0485","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.cell.2012.10.047","article-title":"The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism","volume":"151","author":"Sebasti\u00e1n","year":"2012","journal-title":"Cell"},{"issue":"26","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0490","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1038\/onc.2011.37","article-title":"SirT3 suppresses hypoxia inducible factor 1\u03b1 and tumor growth by inhibiting mitochondrial ROS production","volume":"30","author":"Bell","year":"2011","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0495","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ccr.2013.02.024","article-title":"SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism","volume":"23","author":"Jeong","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0500","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.molcel.2010.05.023","article-title":"Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha","volume":"38","author":"Lim","year":"2010","journal-title":"Mol Cell"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0505","doi-asserted-by":"crossref","first-page":"750","DOI":"10.14348\/molcells.2015.0167","article-title":"Sirtuins in cancer: a balancing act between genome stability and metabolism","volume":"38","author":"Jeong","year":"2015","journal-title":"Mol Cells"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0510","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.tcb.2017.02.004","article-title":"Mitochondria and epigenetics\u2014crosstalk in homeostasis and stress","volume":"27","author":"Matilainen","year":"2017","journal-title":"Trends Cell Biol"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0515","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064705","article-title":"Effects of DNMT1 and HDAC inhibitors on gene-specific methylation reprogramming during porcine somatic cell nuclear transfer","volume":"8","author":"Xu","year":"2013","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0520","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.tcb.2017.05.001","article-title":"Serine and functional metabolites in cancer","volume":"27","author":"Newman","year":"2017","journal-title":"Trends Cell Biol"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0525","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cmet.2015.08.024","article-title":"Histone methylation dynamics and gene regulation occur through the sensing of one-carbon metabolism","volume":"22","author":"Mentch","year":"2015","journal-title":"Cell Metab"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0530","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1101\/gad.191056.112","article-title":"Inhibition of \u03b1-KG-dependent histone and DNA demethylases by fumarate and succinate that are accumulated in mutations of FH and SDH tumor suppressors","volume":"26","author":"Xiao","year":"2012","journal-title":"Genes Dev"},{"issue":"7539","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0535","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nature13981","article-title":"Intracellular \u03b1-ketoglutarate maintains the pluripotency of embryonic stem cells","volume":"518","author":"Carey","year":"2015","journal-title":"Nature"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0540","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1016\/j.celrep.2017.05.014","article-title":"Cancer-associated IDH1 promotes growth and resistance to targeted therapies in the absence of mutation","volume":"19","author":"Calvert","year":"2017","journal-title":"Cell Rep"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0545","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cmet.2015.05.014","article-title":"Acetyl coenzyme a: a central metabolite and second messenger","volume":"21","author":"Pietrocola","year":"2015","journal-title":"Cell Metab"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0550","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.molcel.2016.05.029","article-title":"Interplay between metabolism and epigenetics: a nuclear adaptation to environmental changes","volume":"62","author":"Etchegaray","year":"2016","journal-title":"Mol Cell"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0555","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.molcel.2018.07.015","article-title":"Metabolic signaling to the nucleus in cancer","volume":"71","author":"Campbell","year":"2018","journal-title":"Mol Cell"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0560","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1021\/cb500846u","article-title":"Metabolic regulation of histone post-translational modifications","volume":"10","author":"Fan","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"8","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0565","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4161\/cc.10.8.15330","article-title":"Ketones and lactate increase cancer cell \"stemness,\" driving recurrence, metastasis and poor clinical outcome in breast cancer: achieving personalized medicine via metabolo-genomics","volume":"10","author":"Martinez-Outschoorn","year":"2011","journal-title":"Cell Cycle"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0570","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.1093\/nar\/gks066","article-title":"Lactate, a product of glycolytic metabolism, inhibits histone deacetylase activity and promotes changes in gene expression","volume":"40","author":"Latham","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0575","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12964-015-0114-x","article-title":"l- and d-lactate enhance DNA repair and modulate the resistance of cervical carcinoma cells to anticancer drugs via histone deacetylase inhibition and hydroxycarboxylic acid receptor 1 activation","volume":"13","author":"Wagner","year":"2015","journal-title":"Cell Commun Signal"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0580","first-page":"9(4)","article-title":"Lactate increases renal cell carcinoma aggressiveness through sirtuin 1-dependent epithelial mesenchymal transition axis regulation","author":"Miranda-Gon\u00e7alves","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0585","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tcb.2014.04.002","article-title":"NAD+ and sirtuins in aging and disease","volume":"24","author":"Imai","year":"2014","journal-title":"Trends Cell Biol"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0590","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cmet.2015.05.023","article-title":"NAD(+) metabolism and the control of energy homeostasis: a balancing act between mitochondria and the nucleus","volume":"22","author":"Cant\u00f3","year":"2015","journal-title":"Cell Metab"},{"issue":"15","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0595","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/febs.13295","article-title":"Oncometabolites: tailoring our genes","volume":"282","author":"Nowicki","year":"2015","journal-title":"FEBS J"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0600","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.cmet.2015.06.023","article-title":"Hypoxia induces production of L-2-hydroxyglutarate","volume":"22","author":"Intlekofer","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0605","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.freeradbiomed.2016.04.025","article-title":"Oncometabolites: unconventional triggers of oncogenic signalling cascades","volume":"100","author":"Sciacovelli","year":"2016","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0610","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.stemcr.2015.12.012","article-title":"Oncometabolic nuclear reprogramming of cancer Stemness","volume":"6","author":"Menendez","year":"2016","journal-title":"Stem Cell Reports"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0615","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/brv.12513","article-title":"Oncometabolites in cancer aggressiveness and tumour repopulation","volume":"94","author":"Dando","year":"2019","journal-title":"Biol Rev Camb Philos Soc"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0620","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1021\/acschembio.8b00951","article-title":"Metabolic regulation of the epitranscriptome","volume":"14","author":"Thomas","year":"2019","journal-title":"ACS Chem Biol"},{"issue":"1\u20132","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0625","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.cell.2017.11.031","article-title":"R-2HG exhibits anti-tumor activity by targeting FTO\/m(6)A\/MYC\/CEBPA signaling","volume":"172","author":"Su","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0630","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ccell.2017.04.001","article-title":"IDH mutation, competitive inhibition of FTO, and RNA methylation","volume":"31","author":"Elkashef","year":"2017","journal-title":"Cancer Cell"},{"issue":"7690","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0635","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nature25460","article-title":"Mitochondrial translation requires folate-dependent tRNA methylation","volume":"554","author":"Morscher","year":"2018","journal-title":"Nature"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0640","doi-asserted-by":"crossref","first-page":"e201800036","DOI":"10.26508\/lsa.201800036","article-title":"Serine catabolism is essential to maintain mitochondrial respiration in mammalian cells","volume":"1","author":"Lucas","year":"2018","journal-title":"Life Sci Alliance"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0645","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1016\/j.celrep.2017.11.092","article-title":"S-adenosylmethionine synthesis is regulated by selective N(6)-adenosine methylation and mRNA degradation involving METTL16 and YTHDC1","volume":"21","author":"Shima","year":"2017","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0650","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.cell.2017.05.003","article-title":"The U6 snRNA m(6)A methyltransferase METTL16 regulates SAM synthetase intron retention","volume":"169","author":"Pendleton","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0655","doi-asserted-by":"crossref","DOI":"10.1111\/obr.12942","article-title":"Emerging role of m(6)A RNA methylation in nutritional physiology and metabolism","volume":"21","author":"Wu","year":"2020","journal-title":"Obes Rev"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0660","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1210\/jc.2018-00619","article-title":"Glucose is involved in the dynamic regulation of m6A in patients with type 2 diabetes","volume":"104","author":"Yang","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0665","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13105-015-0420-1","article-title":"FTO-dependent function of N6-methyladenosine is involved in the hepatoprotective effects of betaine on adolescent mice","volume":"71","author":"Chen","year":"2015","journal-title":"J Physiol Biochem"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0670","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1002\/jcb.26746","article-title":"FTO reduces mitochondria and promotes hepatic fat accumulation through RNA demethylation","volume":"119","author":"Kang","year":"2018","journal-title":"J Cell Biochem"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0675","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-020-00895-1","article-title":"Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer","volume":"13","author":"Wang","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0680","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s12943-020-01190-w","article-title":"m(6)A-dependent glycolysis enhances colorectal cancer progression","volume":"19","author":"Shen","year":"2020","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0685","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1038\/s41467-020-16306-5","article-title":"N(6)-methyladenosine regulates glycolysis of cancer cells through PDK4","volume":"11","author":"Li","year":"2020","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0690","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla","year":"2019","journal-title":"World J Oncol"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0695","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0700","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.mcna.2017.03.009","article-title":"Prevention of prostate cancer morbidity and mortality: primary prevention and early detection","volume":"101","author":"Barry","year":"2017","journal-title":"Med Clin North Am"},{"issue":"Suppl 1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0705","first-page":"S3","article-title":"Androgen deprivation therapy in the treatment of advanced prostate cancer","volume":"9","author":"Perlmutter","year":"2007","journal-title":"Rev Urol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0710","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13148-016-0264-8","article-title":"Epigenetic modulators as therapeutic targets in prostate cancer","volume":"8","author":"Gra\u00e7a","year":"2016","journal-title":"Clin Epigenetics"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0715","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","year":"2015","journal-title":"Cell"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0720","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/978-1-4939-1804-1_11","article-title":"Epigenetics of prostate cancer","volume":"1238","author":"McKee","year":"2015","journal-title":"Methods Mol Biol"},{"issue":"22","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0725","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1093\/jnci\/93.22.1747","article-title":"Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma","volume":"93","author":"Jer\u00f3nimo","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0730","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.eururo.2004.06.014","article-title":"Molecular detection of prostate cancer: a role for GSTP1 hypermethylation","volume":"46","author":"Henrique","year":"2004","journal-title":"Eur Urol"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0735","first-page":"847","article-title":"Prostate cancer molecular detection in plasma samples by glutathione S-transferase P1 (GSTP1) methylation analysis","volume":"60","author":"Dumache","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0740","first-page":"9(3)","article-title":"DNA methylation-based testing in liquid biopsies as detection and prognostic biomarkers for the four major cancer types","author":"Const\u00e2ncio","year":"2020","journal-title":"Cells"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0745","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/path.1503","article-title":"Aberrant CpG island hypermethylation of multiple genes in prostate cancer and prostatic intraepithelial neoplasia","volume":"202","author":"Kang","year":"2004","journal-title":"J Pathol"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0750","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1158\/1078-0432.CCR-11-2090","article-title":"Global methylation profiling for risk prediction of prostate cancer","volume":"18","author":"Mahapatra","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0755","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.bjc.6604199","article-title":"Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy","volume":"98","author":"Weichert","year":"2008","journal-title":"Br J Cancer"},{"issue":"6907","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0760","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature01075","article-title":"The polycomb group protein EZH2 is involved in progression of prostate cancer","volume":"419","author":"Varambally","year":"2002","journal-title":"Nature"},{"issue":"25","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0765","doi-asserted-by":"crossref","first-page":"9911","DOI":"10.1074\/jbc.RA119.008152","article-title":"Inhibition of enhancer of zeste homolog 2 (EZH2) overcomes enzalutamide resistance in castration-resistant prostate cancer","volume":"294","author":"Bai","year":"2019","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0770","doi-asserted-by":"crossref","first-page":"11341","DOI":"10.1158\/0008-5472.CAN-06-1570","article-title":"Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence","volume":"66","author":"Kahl","year":"2006","journal-title":"Cancer Res"},{"issue":"7057","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0775","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature04020","article-title":"LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription","volume":"437","author":"Metzger","year":"2005","journal-title":"Nature"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0780","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/pcan.2016.21","article-title":"Reversible lysine-specific demethylase 1 antagonist HCI-2509 inhibits growth and decreases c-MYC in castration- and docetaxel-resistant prostate cancer cells","volume":"19","author":"Gupta","year":"2016","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0785","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1158\/0008-5472.CAN-12-4300","article-title":"KDM4\/JMJD2 histone demethylases: epigenetic regulators in cancer cells","volume":"73","author":"Berry","year":"2013","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0790","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/ncb1546","article-title":"Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expression","volume":"9","author":"Wissmann","year":"2007","journal-title":"Nat Cell Biol"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0795","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41388-018-0414-x","article-title":"KDM8\/JMJD5 as a dual coactivator of AR and PKM2 integrates AR\/EZH2 network and tumor metabolism in CRPC","volume":"38","author":"Wang","year":"2019","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0800","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3390\/genes9110552","article-title":"The emerging role of epitranscriptomics in cancer: focus on urological Tumors","volume":"9","author":"Lobo","year":"2018","journal-title":"Genes"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0805","doi-asserted-by":"crossref","first-page":"e9589","DOI":"10.7717\/peerj.9589","article-title":"Role of methyltransferase-like enzyme 3 and methyltransferase-like enzyme 14 in urological cancers","volume":"8","author":"Tao","year":"2020","journal-title":"PeerJ"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0810","first-page":"9(11)","article-title":"The emerging role of epitranscriptomics in cancer: focus on urological tumors","author":"Lobo","year":"2018","journal-title":"Genes (Basel)"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0815","first-page":"12(4)","article-title":"VIRMA-dependent N6-methyladenosine modifications regulate the expression of long non-coding RNAs CCAT1 and CCAT2 in prostate cancer","author":"Barros-Silva","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0820","doi-asserted-by":"crossref","DOI":"10.2217\/fon-2020-0330","article-title":"The m6A methylation regulator-based signature for predicting the prognosis of prostate cancer","author":"Wang","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0825","doi-asserted-by":"crossref","first-page":"9143","DOI":"10.2147\/OTT.S226796","article-title":"RNA m(6)A methyltransferase METTL3 promotes the growth of prostate cancer by regulating hedgehog pathway","volume":"12","author":"Cai","year":"2019","journal-title":"Onco Targets Ther"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0830","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.euo.2018.06.010","article-title":"The metabolic landscape of prostate cancer","volume":"2","author":"Giunchi","year":"2019","journal-title":"Eur Urol Oncol"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0835","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.bbalip.2013.03.010","article-title":"The fat side of prostate cancer","volume":"1831","author":"Zadra","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0840","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.chembiol.2011.05.009","article-title":"Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer","volume":"18","author":"Nomura","year":"2011","journal-title":"Chem Biol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2020.07.013","article-title":"Lipids and cancer: emerging roles in pathogenesis, diagnosis and therapeutic intervention","author":"Butler","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0850","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00432-015-1992-4","article-title":"Androgens enhance the glycolytic metabolism and lactate export in prostate cancer cells by modulating the expression of GLUT1, GLUT3, PFK, LDH and MCT4 genes","volume":"142","author":"Vaz","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"issue":"43","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0855","doi-asserted-by":"crossref","first-page":"29937","DOI":"10.1074\/jbc.M114.573659","article-title":"Regulation of lipogenic gene expression by lysine-specific histone demethylase-1 (LSD1)","volume":"289","author":"Abdulla","year":"2014","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0860","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/cas.13004","article-title":"Histone demethylase LSD1 controls the phenotypic plasticity of cancer cells","volume":"107","author":"Hino","year":"2016","journal-title":"Cancer Sci"},{"issue":"39","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0865","doi-asserted-by":"crossref","first-page":"30034","DOI":"10.1074\/jbc.M110.151209","article-title":"Histone demethylase LSD1 regulates adipogenesis","volume":"285","author":"Musri","year":"2010","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0870","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1158\/0008-5472.CAN-14-1560","article-title":"Lysine demethylase LSD1 coordinates glycolytic and mitochondrial metabolism in hepatocellular carcinoma cells","volume":"75","author":"Sakamoto","year":"2015","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0875","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.3892\/or.2017.5430","article-title":"Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b\/HK2 axis","volume":"37","author":"Tao","year":"2017","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0880","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1073\/pnas.1311249111","article-title":"JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1\u03b1-mediated glucose metabolism","volume":"111","author":"Wang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0885","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.celrep.2015.12.053","article-title":"KDM4C and ATF4 cooperate in transcriptional control of amino acid metabolism","volume":"14","author":"Zhao","year":"2016","journal-title":"Cell Rep"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0890","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ccell.2019.02.014","article-title":"Serine and methionine metabolism: vulnerabilities in lethal prostate cancer","volume":"35","author":"Gao","year":"2019","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0895","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.ccell.2019.01.018","article-title":"Increased serine and one-carbon pathway metabolism by PKC\u03bb\/\u03b9 deficiency promotes neuroendocrine prostate cancer","volume":"35","author":"Reina-Campos","year":"2019","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0900","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajur.2019.12.003","article-title":"Lipogenic effects of androgen signaling in normal and malignant prostate","volume":"7","author":"Mah","year":"2020","journal-title":"Asian J Urol"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0905","first-page":"111","article-title":"Lipid metabolism in prostate cancer","volume":"2","author":"Wu","year":"2014","journal-title":"Am J Clin Exp Urol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0910","first-page":"8(10)","article-title":"CPT1A supports castration-resistant prostate cancer in androgen-deprived conditions","author":"Joshi","year":"2019","journal-title":"Cells"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0915","doi-asserted-by":"crossref","first-page":"17022","DOI":"10.1038\/nrdp.2017.22","article-title":"Bladder cancer","volume":"3","author":"Sanli","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0920","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/path.4886","article-title":"Molecular classification of urothelial carcinoma: global mRNA classification versus tumour-cell phenotype classification","volume":"242","author":"Sj\u00f6dahl","year":"2017","journal-title":"J Pathol"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0925","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","article-title":"Comprehensive molecular characterization of muscle-invasive bladder cancer","volume":"171","author":"Robertson","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0930","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s11934-018-0861-5","article-title":"Epigenetic alterations in bladder cancer","volume":"19","author":"Porten","year":"2018","journal-title":"Curr Urol Rep"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0935","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejca.2013.08.025","article-title":"Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylation","volume":"50","author":"Monteiro-Reis","year":"2014","journal-title":"Eur J Cancer"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0940","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1158\/1078-0432.CCR-06-2476","article-title":"Promoter hypermethylation identifies progression risk in bladder cancer","volume":"13","author":"Yates","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"3\u20134","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0945","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000158665","article-title":"Promoter hypermethylation in tumour suppressor genes shows association with stage, grade and invasiveness of bladder cancer","volume":"75","author":"Jarmalaite","year":"2008","journal-title":"Oncology"},{"issue":"20","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0950","doi-asserted-by":"crossref","first-page":"8169","DOI":"10.1158\/0008-5472.CAN-10-1335","article-title":"Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue","volume":"70","author":"Wolff","year":"2010","journal-title":"Cancer Res"},{"issue":"7492","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0955","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature12965","volume":"507","year":"2014","journal-title":"Nature"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0960","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/ng.907","article-title":"Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder","volume":"43","author":"Gui","year":"2011","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0965","first-page":"349","article-title":"Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas","volume":"16","author":"Weikert","year":"2005","journal-title":"Int J Mol Med"},{"issue":"Suppl. 2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0970","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.5213\/inj.1632752.376","article-title":"Genetic and epigenetic alterations in bladder cancer","volume":"20","author":"Li","year":"2016","journal-title":"Int Neurourol J"},{"issue":"8","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0975","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/j.urolonc.2012.06.015","article-title":"Changes in histone deacetylase (HDAC) expression patterns and activity of HDAC inhibitors in urothelial cancers","volume":"31","author":"Niegisch","year":"2013","journal-title":"Urol Oncol"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0980","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/mc.22117","article-title":"Phenotypic impact of deregulated expression of class I histone deacetylases in urothelial cell carcinoma of the bladder","volume":"54","author":"Junqueira-Neto","year":"2015","journal-title":"Mol Carcinog"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0985","first-page":"12(5)","article-title":"Sirtuins' deregulation in bladder cancer: SIRT7 is implicated in tumor progression through epithelial to mesenchymal transition promotion","author":"Monteiro-Reis","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb0990","first-page":"39(12)","article-title":"m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer","author":"Chen","year":"2019","journal-title":"Biosci Rep"},{"issue":"19","key":"10.1016\/B978-0-323-85652-2.00019-1_bb0995","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1038\/s41388-019-0683-z","article-title":"The m(6)A methyltransferase METTL3 promotes bladder cancer progression via AFF4\/NF-\u03baB\/MYC signaling network","volume":"38","author":"Cheng","year":"2019","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1000","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1111\/jcmm.15063","article-title":"METTL3\/YTHDF2 m(6)A axis promotes tumorigenesis by degrading SETD7 and KLF4 mRNAs in bladder cancer","volume":"24","author":"Xie","year":"2020","journal-title":"J Cell Mol Med"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1005","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12943-019-1084-1","article-title":"Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N(6)-methyladenosine of Notch1","volume":"18","author":"Gu","year":"2019","journal-title":"Mol Cancer"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.urolonc.2018.04.010","article-title":"Metabolic changes in bladder cancer","volume":"36","author":"Woolbright","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1015","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ctrv.2016.03.005","article-title":"Metabolic phenotype of bladder cancer","volume":"45","author":"Massari","year":"2016","journal-title":"Cancer Treat Rev"},{"issue":"17","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1020","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.18632\/oncotarget.24229","article-title":"Reprogrammed lipid metabolism in bladder cancer with cisplatin resistance","volume":"9","author":"Lee","year":"2018","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1025","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1055\/s-2003-43500","article-title":"Increased activity of glycerol 3-phosphate dehydrogenase and other lipogenic enzymes in human bladder cancer","volume":"35","author":"Turyn","year":"2003","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1030","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11306-018-1361-9","article-title":"Volatile metabolomic signature of bladder cancer cell lines based on gas chromatography-mass spectrometry","volume":"14","author":"Rodrigues","year":"2018","journal-title":"Metabolomics"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1035","first-page":"9(1)","article-title":"GC-MS metabolomics reveals distinct profiles of low- and high-grade bladder cancer cultured cells","author":"Rodrigues","year":"2019","journal-title":"Metabolites"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1040","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrurol.2015.111","article-title":"Targeting glycogen metabolism in bladder cancer","volume":"12","author":"Ritterson Lew","year":"2015","journal-title":"Nat Rev Urol"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1045","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.18632\/oncotarget.12157","article-title":"Sirtuins in glucose and lipid metabolism","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1050","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.semcancer.2018.11.003","article-title":"The roles of sirtuins family in cell metabolism during tumor development","volume":"57","author":"Zhu","year":"2019","journal-title":"Semin Cancer Biol"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1055","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s13577-019-00237-5","article-title":"SIRT1 promotes GLUT1 expression and bladder cancer progression via regulation of glucose uptake","volume":"32","author":"Chen","year":"2019","journal-title":"Hum Cell"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1060","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13148-020-00862-0","article-title":"Symphony of epigenetic and metabolic regulation-interaction between the histone methyltransferase EZH2 and metabolism of tumor","volume":"12","author":"Zhang","year":"2020","journal-title":"Clin Epigenetics"},{"issue":"16","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1065","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.7150\/thno.25130","article-title":"Rewiring of cisplatin-resistant bladder cancer cells through epigenetic regulation of genes involved in amino acid metabolism","volume":"8","author":"Yeon","year":"2018","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1070","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.celrep.2016.10.012","article-title":"Lipids reprogram metabolism to become a major carbon source for histone acetylation","volume":"17","author":"McDonnell","year":"2016","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1075","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s41389-020-0230-3","article-title":"Acetyl-CoA synthetase 3 promotes bladder cancer cell growth under metabolic stress","volume":"9","author":"Zhang","year":"2020","journal-title":"Oncogenesis"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1080","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1085","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1090","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/s41585-019-0211-5","article-title":"The cancer genome atlas of renal cell carcinoma: findings and clinical implications","volume":"16","author":"Linehan","year":"2019","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1095","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-05-3074","article-title":"Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer","volume":"66","author":"Banks","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.ackd.2013.10.001","article-title":"Hereditary kidney cancer syndromes","volume":"21","author":"Haas","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1505917","article-title":"Comprehensive molecular characterization of papillary renal-cell carcinoma","volume":"374","author":"Linehan","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3109\/00365590903286697","article-title":"Prognostic factors and long-term survival in renal cell cancer patients","volume":"43","author":"Sunela","year":"2009","journal-title":"Scand J Urol Nephrol"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1115","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1080\/14737140.2016.1222908","article-title":"Renal cell cancer: overview of the current therapeutic landscape","volume":"16","author":"Erman","year":"2016","journal-title":"Expert Rev Anticancer Ther"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1120","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nrg3142","article-title":"Epigenetics and the environment: emerging patterns and implications","volume":"13","author":"Feil","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1125","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrneph.2016.168","article-title":"The epigenetic landscape of renal cancer","volume":"13","author":"Morris","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1130","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41585-018-0052-7","article-title":"Epigenetic modifiers: activities in renal cell carcinoma","volume":"15","author":"de Cubas","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1135","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41585-018-0023-z","article-title":"Epigenetics in renal cell cancer: mechanisms and clinical applications","volume":"15","author":"Joosten","year":"2018","journal-title":"Nat Rev Urol"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s40291-018-0337-9","article-title":"The role of DNA methylation in renal cell carcinoma","volume":"22","author":"Lasseigne","year":"2018","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1145","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.celrep.2018.03.075","article-title":"The cancer genome atlas comprehensive molecular characterization of renal cell carcinoma","volume":"23","author":"Ricketts","year":"2018","journal-title":"Cell Rep"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1150","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/pin.12001","article-title":"Expression of EZH2 in renal cell carcinoma as a novel prognostic marker","volume":"62","author":"Lee","year":"2012","journal-title":"Pathol Int"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1155","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/ijc.25250","article-title":"Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma","volume":"127","author":"Ellinger","year":"2010","journal-title":"Int J Cancer"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1160","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1464-410X.2011.10278.x","article-title":"Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma","volume":"109","author":"Rogenhofer","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1165","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/1471-2407-8-381","article-title":"Class I histone deacetylases 1, 2 and 3 are highly expressed in renal cell cancer","volume":"8","author":"Fritzsche","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1170","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1186\/s12885-016-2604-7","article-title":"HDAC 1 and 6 modulate cell invasion and migration in clear cell renal cell carcinoma","volume":"16","author":"Ramakrishnan","year":"2016","journal-title":"BMC Cancer"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1175","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1111\/j.1349-7006.2010.01717.x","article-title":"Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma","volume":"101","author":"Mosashvilli","year":"2010","journal-title":"Cancer Sci"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1180","doi-asserted-by":"crossref","first-page":"675.e9","DOI":"10.1016\/j.urolonc.2017.08.016","article-title":"Differential expression of the sirtuin family in renal cell carcinoma: aspects of carcinogenesis and prognostic significance","volume":"35","author":"Jeh","year":"2017","journal-title":"Urol Oncol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fonc.2020.00003","article-title":"Effect of m(6)A RNA methylation regulators on malignant progression and prognosis in renal clear cell carcinoma","volume":"10","author":"Wang","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1190","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12935-020-01238-3","article-title":"Identification of a m(6)A RNA methylation regulators-based signature for predicting the prognosis of clear cell renal carcinoma","volume":"20","author":"Chen","year":"2020","journal-title":"Cancer Cell Int"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1195","doi-asserted-by":"crossref","first-page":"5648783","DOI":"10.1155\/2019\/5648783","article-title":"Identification of METTL14 in kidney renal clear cell carcinoma using bioinformatics analysis","volume":"2019","author":"Wang","year":"2019","journal-title":"Dis Markers"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1200","doi-asserted-by":"crossref","first-page":"646","DOI":"10.21037\/atm-20-3079","article-title":"ALKBH5 promotes the proliferation of renal cell carcinoma by regulating AURKB expression in an m(6)A-dependent manner","volume":"8","author":"Zhang","year":"2020","journal-title":"Ann Transl Med"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1205","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bbcan.2018.06.003","article-title":"Genetic and metabolic hallmarks of clear cell renal cell carcinoma","volume":"1870","author":"Sanchez","year":"2018","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"8","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1210","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1080\/07853890310018458","article-title":"The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase","volume":"35","author":"Pollard","year":"2003","journal-title":"Ann Med"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1215","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrneph.2017.59","article-title":"Metabolic reprogramming in clear cell renal cell carcinoma","volume":"13","author":"Wettersten","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1220","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1152\/japplphysiol.01069.2001","article-title":"Changes in MCT 1, MCT 4, and LDH expression are tissue specific in rats after long-term hypobaric hypoxia","volume":"92","author":"McClelland","year":"2002","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1225","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1038\/s41598-020-62853-8","article-title":"Network-based metabolic characterization of renal cell carcinoma","volume":"10","author":"Pandey","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1230","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/nrc3810","article-title":"Tumorigenesis: FBP1 is suppressed in kidney tumours","volume":"14","author":"Alderton","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"29","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1235","doi-asserted-by":"crossref","first-page":"45134","DOI":"10.18632\/oncotarget.9761","article-title":"EZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1\u03b1 signaling","volume":"7","author":"Pang","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1240","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1074\/jbc.M115.688762","article-title":"Fumarate and succinate regulate expression of hypoxia-inducible genes via TET enzymes","volume":"291","author":"Laukka","year":"2016","journal-title":"J Biol Chem"},{"issue":"7621","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1245","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature19353","article-title":"Fumarate is an epigenetic modifier that elicits epithelial-to-mesenchymal transition","volume":"537","author":"Sciacovelli","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1250","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"issue":"24","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1255","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1158\/1078-0432.CCR-18-1727","article-title":"Biochemical and epigenetic insights into L-2-hydroxyglutarate, a potential therapeutic target in renal cancer","volume":"24","author":"Shelar","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1260","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1158\/2159-8290.CD-13-0696","article-title":"L-2-Hydroxyglutarate: an epigenetic modifier and putative oncometabolite in renal cancer","volume":"4","author":"Shim","year":"2014","journal-title":"Cancer Discov"},{"issue":"34","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1265","doi-asserted-by":"crossref","first-page":"6211","DOI":"10.1038\/s41388-019-0869-4","article-title":"MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma","volume":"38","author":"Green","year":"2019","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1270","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1111\/jcmm.14128","article-title":"N6-methyladenosine demethylase FTO suppresses clear cell renal cell carcinoma through a novel FTO-PGC-1\u03b1 signalling axis","volume":"23","author":"Zhuang","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"35","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1275","doi-asserted-by":"crossref","first-page":"21441","DOI":"10.1073\/pnas.2000516117","article-title":"The m(6)A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor","volume":"117","author":"Xiao","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1280","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41572-018-0029-0","article-title":"Testicular cancer","volume":"4","author":"Cheng","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1285","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.humpath.2018.07.016","article-title":"Testicular germ cell tumors: revisiting a series in light of the new WHO classification and AJCC staging systems, focusing on challenges for pathologists","volume":"82","author":"Lobo","year":"2018","journal-title":"Hum Pathol"},{"issue":"10029","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1290","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(15)00991-5","article-title":"Testicular germ cell tumours","volume":"387","author":"Rajpert-De Meyts","year":"2016","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1295","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.celrep.2018.05.039","article-title":"Integrated molecular characterization of testicular germ cell tumors","volume":"23","author":"Shen","year":"2018","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1300","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/andr.293","article-title":"International patterns and trends in testicular cancer incidence, overall and by histologic subtype, 1973\u20132007","volume":"3","author":"Trabert","year":"2015","journal-title":"Andrology"},{"issue":"11","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1305","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1038\/modpathol.2008.127","article-title":"Global DNA hypomethylation in intratubular germ cell neoplasia and seminoma, but not in nonseminomatous male germ cell tumors","volume":"21","author":"Netto","year":"2008","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1310","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2217\/epi-2016-0081","article-title":"The epigenetics of testicular germ cell tumors: looking for novel disease biomarkers","volume":"9","author":"Costa","year":"2017","journal-title":"Epigenomics"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1315","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11091385","article-title":"XIST-promoter demethylation as tissue biomarker for testicular germ cell tumors and spermatogenesis quality","volume":"11","author":"Lobo","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1320","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121637","article-title":"Identification and validation model for informative liquid biopsy-based microRNA biomarkers: insights from germ cell tumor in vitro, in vivo and patient-derived data","volume":"8","author":"Lobo","year":"2019","journal-title":"Cells"},{"issue":"1748","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1325","doi-asserted-by":"crossref","DOI":"10.1098\/rstb.2017.0338","article-title":"Germ cell tumour subtypes display differential expression of microRNA371a-3p","volume":"373","author":"Vilela-Salgueiro","year":"2018","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1330","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.eururo.2016.08.013","article-title":"Testicular germ cell tumors go epigenetics: will miR-371a-3p replace classical serum biomarkers?","volume":"71","author":"Henrique","year":"2017","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1335","doi-asserted-by":"crossref","DOI":"10.3390\/cancers11010006","article-title":"The role of DNA\/histone modifying enzymes and chromatin remodeling complexes in testicular germ cell tumors","volume":"11","author":"Lobo","year":"2018","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1340","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12967-019-1837-z","article-title":"m(6)A RNA modification and its writer\/reader VIRMA\/YTHDF3 in testicular germ cell tumors: a role in seminoma phenotype maintenance","volume":"17","author":"Lobo","year":"2019","journal-title":"J Transl Med"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1345","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/nrurol.2016.170","article-title":"The present and future of serum diagnostic tests for testicular germ cell tumours","volume":"13","author":"Murray","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1350","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S0090-4295(99)00272-1","article-title":"Does positron emission tomography using 18-fluoro-2-deoxyglucose improve clinical staging of testicular cancer?\u2014results of a study in 50 patients","volume":"54","author":"Cremerius","year":"1999","journal-title":"Urology"},{"issue":"4a","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1355","first-page":"2747","article-title":"Immunohistochemical detection of Glut3 in human tumors and normal tissues","volume":"17","author":"Younes","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1360","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fendo.2019.00417","article-title":"The Warburg effect is associated with tumor aggressiveness in testicular germ cell tumors","volume":"10","author":"Bonatelli","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"29","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1365","doi-asserted-by":"crossref","first-page":"20386","DOI":"10.18632\/oncotarget.24910","article-title":"The clinicopathological significance of monocarboxylate transporters in testicular germ cell tumors","volume":"9","author":"Silva","year":"2018","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1370","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00428-013-1525-y","article-title":"Fatty acid synthase overexpression in adult testicular germ cell tumors: potential role in the progression of non-seminomatous germ cell tumors","volume":"464","author":"Miyai","year":"2014","journal-title":"Virchows Arch"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1375","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3892\/mmr.2016.5472","article-title":"microRNA-199a-3p functions as tumor suppressor by regulating glucose metabolism in testicular germ cell tumors","volume":"14","author":"Liu","year":"2016","journal-title":"Mol Med Rep"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1380","first-page":"2163","article-title":"miR-199a-3p\/Sp1\/LDHA axis controls aerobic glycolysis in testicular tumor cells","volume":"42","author":"Zhou","year":"2018","journal-title":"Int J Mol Med"},{"key":"10.1016\/B978-0-323-85652-2.00019-1_bb1385","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.gde.2017.03.015","article-title":"The promise of epigenetic therapy: reprogramming the cancer epigenome","volume":"42","author":"Kelly","year":"2017","journal-title":"Curr Opin Genet Dev"},{"issue":"10","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1390","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat Rev Genet"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1395","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1080\/15592294.2019.1640546","article-title":"Epidrugs: targeting epigenetic marks in cancer treatment","volume":"14","author":"Miranda Furtado","year":"2019","journal-title":"Epigenetics"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1400","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1158\/1535-7163.MCT-09-0013","article-title":"DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation","volume":"8","author":"Miranda","year":"2009","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1405","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/ml3003346","article-title":"Identification of potent, selective, cell-active inhibitors of the histone lysine methyltransferase EZH2","volume":"3","author":"Verma","year":"2012","journal-title":"ACS Med Chem Lett"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1410","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11306-009-0192-0","article-title":"Histone deacetylase inhibition results in a common metabolic profile associated with HT29 differentiation","volume":"6","author":"Alcarraz-Viz\u00e1n","year":"2010","journal-title":"Metabolomics"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1415","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/me.2008-0179","article-title":"Glucose metabolism as a target of histone deacetylase inhibitors","volume":"23","author":"Wardell","year":"2009","journal-title":"Mol Endocrinol"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1420","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcb.25036","article-title":"Reciprocal modulation of histone deacetylase inhibitors sodium butyrate and trichostatin A on the energy metabolism of breast cancer cells","volume":"116","author":"Rodrigues","year":"2015","journal-title":"J Cell Biochem"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022264","article-title":"Energy metabolism in H460 lung cancer cells: effects of histone deacetylase inhibitors","volume":"6","author":"Amo\u00eado","year":"2011","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1430","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.18632\/oncotarget.2929","article-title":"Glycolytic metabolism influences global chromatin structure","volume":"6","author":"Liu","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1435","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.cmet.2015.02.002","article-title":"Glycolysis-mediated changes in acetyl-CoA and histone acetylation control the early differentiation of embryonic stem cells","volume":"21","author":"Moussaieff","year":"2015","journal-title":"Cell Metab"},{"issue":"3","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1440","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10549-011-1871-x","article-title":"An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression","volume":"133","author":"Simpson","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"6132","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1445","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1126\/science.1236062","article-title":"An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells","volume":"340","author":"Rohle","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1450","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1158\/2159-8290.CD-16-1034","article-title":"AG-221, a first-in-class therapy targeting acute myeloid leukemia harboring oncogenic IDH2 mutations","volume":"7","author":"Yen","year":"2017","journal-title":"Cancer Discov"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1455","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12943-020-01216-3","article-title":"Mechanism of RNA modification N6-methyladenosine in human cancer","volume":"19","author":"Zhou","year":"2020","journal-title":"Mol Cancer"},{"issue":"1","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1460","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/nar\/gku1276","article-title":"Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5","volume":"43","author":"Huang","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1465","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ccell.2019.03.006","article-title":"Small-molecule targeting of oncogenic FTO demethylase in acute myeloid leukemia","volume":"35","author":"Huang","year":"2019","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159072","article-title":"Important role of FTO in the survival of rare panresistant triple-negative inflammatory breast cancer cells facing a severe metabolic challenge","volume":"11","author":"Singh","year":"2016","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1475","first-page":"621","article-title":"The epitranscriptome m6A writer METTL3 promotes chemo- and radioresistance in pancreatic cancer cells","volume":"52","author":"Taketo","year":"2018","journal-title":"Int J Oncol"},{"issue":"4","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1480","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.cell.2013.10.026","article-title":"RNA-methylation-dependent RNA processing controls the speed of the circadian clock","volume":"155","author":"Fustin","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1485","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 inhibits hematopoietic stem\/progenitor differentiation and promotes leukemogenesis via mRNA m(6)A modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/B978-0-323-85652-2.00019-1_bb1490","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1136\/gutjnl-2014-308614","article-title":"Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signalling pathway through targeting the WTAP-WT1-TBL1 axis","volume":"65","author":"Zhang","year":"2016","journal-title":"Gut"}],"container-title":["Epigenetics and Metabolomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323856522000191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:B9780323856522000191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:59:17Z","timestamp":1758135557000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/B9780323856522000191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9780323856522"],"references-count":297,"URL":"https:\/\/doi.org\/10.1016\/b978-0-323-85652-2.00019-1","relation":{},"subject":[],"published":{"date-parts":[[2021]]}}}